Concepedia

Kenneth Lawrence

KL

28

Publications

1.2K

Citations

21

H-Index

1983

Active since

Affiliations

Tetraphase Pharmaceuticals (United States)(Current)

Entasis Therapeutics (United States)

Tufts Medical Center

Kansas State University

New Frontier

Kenneth Lawrence is an author at Tetraphase Pharmaceuticals (United States) specializing in medicine, infection control, and metabolism.

ORCID

Top concepts

Publications per year

1983–2020

28

Publications

28

Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea

Stephanie N. Taylor, Jeanne Marrazzo, Byron E. Batteiger et al. · New England Journal of Medicine · 2018 · 219 citations · Full text

IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs Meropenem in the Treatment of Complicated Intraabdominal Infections

Joseph S. Solomkin, Jānis Gardovskis, Kenneth Lawrence et al. · Clinical Infectious Diseases · 2018 · 187 citations · Full text

Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases

Gregory S. Basarab, Günther Kern, John McNulty et al. · Scientific Reports · 2015 · 100 citations · Full text

Comparison of Dosing Recommendations for Antimicrobial Drugs Based on Two Methods for Assessing Kidney Function: Cockcroft‐Gault and Modification of Diet in Renal Disease

Monica V. Golik, Kenneth Lawrence · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2008 · 74 citations

Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017

Vikas Gupta, Gang Ye, Melanie Olesky et al. · BMC Infectious Diseases · 2019 · 64 citations · Full text

Rows per page

1–5 of 28